MUSTANG BIO INC (MBIO) Stock Analyst Earnings Estimates
NASDAQ:MBIO - Nasdaq - US62818Q3020 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A 405.45% | N/A 128.59% | N/A 41.94% | N/A 40.41% | |||||||||||
| EBITDA YoY % growth | N/A | N/A | -31.79M | -30.59M 3.77% | -44.63M -45.90% | -55.13M -23.53% | -64.55M -17.09% | -73.44M -13.77% | -48.245M 34.31% | -11.487M 76.19% | N/A -91.80% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -4.3M | -11.36M -164.19% | -31.79M -179.84% | -31.22M 1.79% | -45.89M -46.99% | -56.81M -23.80% | -66.72M -17.44% | -76.16M -14.15% | -50.47M 33.73% | -12.31M 75.61% | N/A -78.98% | N/A -223.61% | N/A 46.92% | N/A 157.41% | N/A 201.41% | N/A 92.52% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -862.50 -29.59% | -975.00 -13.04% | -862.50 11.54% | -570.00 33.91% | -562.50 1.32% | -316.00 43.82% | N/A 90.16% | N/A 42.62% | N/A 88.69% | N/A 47.98% | N/A 157.28% | N/A 201.69% | N/A 92.13% |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -37.95 11.74% | -8.16 | -29.79 | -365.07% |
| Q3 2024 Q2Q % growth | -2.00 97.14% | -6.63 | 4.63 | 69.83% |
| Q2 2024 Q2Q % growth | 99.10% | -0.90 | % | |
| Q1 2024 Q2Q % growth | 99.14% | -0.89 | % | |
| Q4 2023 Q2Q % growth | -43.00 68.15% | -67.83 | 24.83 | 36.61% |
| Q3 2023 Q2Q % growth | -70.00 48.15% | -65.03 | -4.97 | -7.65% |
| Q2 2023 Q2Q % growth | -100.00 29.82% | -92.18 | -7.82 | -8.48% |
| Q1 2023 Q2Q % growth | -103.00 31.33% | -153.51 | 50.51 | 32.90% |
| Q4 2022 Q2Q % growth | -135.00 18.18% | -147.26 | 12.26 | 8.33% |
| Q3 2022 Q2Q % growth | -135.00 5.26% | -151.09 | 16.09 | 10.65% |
| Q2 2022 Q2Q % growth | -142.50 -18.75% | -159.12 | 16.62 | 10.44% |
| Q1 2022 Q2Q % growth | -150.00 -5.26% | -140.76 | -9.24 | -6.56% |
| Q4 2021 Q2Q % growth | -165.00 31.25% | -146.88 | -18.12 | -12.34% |
| Q3 2021 Q2Q % growth | -142.50 17.39% | -136.17 | -6.33 | -4.65% |
| Q2 2021 Q2Q % growth | -120.00 50.00% | -151.09 | 31.09 | 20.58% |
| Q1 2021 Q2Q % growth | -142.50 32.14% | -149.18 | 6.68 | 4.47% |
| Q4 2020 Q2Q % growth | -240.00 23.81% | -158.74 | -81.26 | -51.19% |
| Q3 2020 Q2Q % growth | -172.50 8.00% | -191.25 | 18.75 | 9.80% |
| Q2 2020 Q2Q % growth | -240.00 -10.34% | -204.00 | -36.00 | -17.65% |
| Q1 2020 Q2Q % growth | -210.00 17.65% | -234.60 | 24.60 | 10.49% |
| Q4 2019 Q2Q % growth | -315.00 | -201.45 | -113.55 | -56.37% |
| Q3 2019 Q2Q % growth | -187.50 | -201.45 | 13.95 | 6.92% |
| Q2 2019 Q2Q % growth | -217.50 | -193.80 | -23.70 | -12.23% |
| Q1 2019 Q2Q % growth | -255.00 | -279.23 | 24.23 | 8.68% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | 0% |
| Revenue | N/A | N/A | N/A | N/A |